GSA Capital Partners’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
WAM
KCM
GSA Capital Partners's GOSS Position: Q2 2026 in Review
GSA Capital Partners increased its Gossamer Bio (GOSS) stake by 361% in Q2 2026, buying an estimated $3.27M and bringing the position to 14,986,947 shares worth $2.47M. The position accounts for 0.16% of the portfolio, ranked #99.
GSA Capital Partners first reported a position in GOSS in Q1 2020 and has held it in 19 quarters since. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- GSA Capital Partners held 14,986,947 shares of Gossamer Bio worth $2.47M as of Q2 2026.
- GSA Capital Partners bought 11,732,714 Gossamer Bio shares in Q2 2026, an estimated $3.27M.
- Gossamer Bio made up 0.16% of GSA Capital Partners's portfolio in Q2 2026, its #99 holding.
- GSA Capital Partners first reported a position in Gossamer Bio in Q1 2020 and has held it in 19 quarters since.
- 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.